{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:37:16Z","timestamp":1760240236742},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.cld.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T02:18:05Z","timestamp":1356056285000},"page":"211-227","source":"Crossref","is-referenced-by-count":8,"title":["Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"17","author":[{"given":"Claudia O.","family":"Zein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2012.11.003_bib1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0016-5085(83)80085-7","article-title":"Familial occurrence of primary sclerosing cholangitis and ulcerative colitis","volume":"85","author":"Quigley","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0031-1276647","article-title":"Deciphering the genetic predisposition to primary sclerosing cholangitis","volume":"31","author":"Karlsen","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.003_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2012.11.003_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cld.2012.11.003_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-0039.2006.00738.x","article-title":"Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes","volume":"69","author":"Wiencke","year":"2007","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.cld.2012.11.003_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clinre.2012.02.003","article-title":"Genetics in primary sclerosing cholangitis","volume":"36","author":"Naess","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0025-6196(12)60897-0","article-title":"Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis","volume":"68","author":"Hashimoto","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.cld.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0168-8278(89)90073-1","article-title":"Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis","volume":"9","author":"Snook","year":"1989","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510240317","article-title":"Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ cells","volume":"24","author":"Leon","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsA","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.003_bib15","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840030203","article-title":"Elevated circulating immune complexes in primary sclerosing cholangitis","volume":"3","author":"Bodenheimer","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/0016-5085(89)90386-7","article-title":"Activation of the complement system in primary sclerosing cholangitis","volume":"97","author":"Senaldi","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/CRIAI:28:2:093","article-title":"Immunopathogenesis of primary sclerosing cholangitis","volume":"28","author":"Worthington","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2012.11.003_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-8278(98)80058-5","article-title":"Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"29","author":"Sasatomi","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-933560","article-title":"Primary sclerosing cholangitis: epidemiology, natural history, and prognosis","volume":"26","author":"Levy","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.003_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2012.11.003_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"Mitchell","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.003_bib24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","article-title":"Risk of primary sclerosing cholangitis is associated with nonsmoking behavior","volume":"110","author":"Van Erpecum","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib29","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib32","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.003_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.003_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.11.003_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib38","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.39.4.594","article-title":"Increased gall bladder volume in primary sclerosing cholangitis","volume":"39","author":"Van de Meeberg","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.003_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1259\/bjr.71.852.10319001","article-title":"The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis","volume":"71","author":"Johnson","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cld.2012.11.003_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.149.1.6412283","article-title":"Primary sclerosing cholangitis: findings on cholangiography and pancreatography","volume":"149","author":"MacCarty","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2012.11.003_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis. AASLD practice guidelines","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance imaging in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.215.1.r00ap2671","article-title":"Primary sclerosing cholangitis: evaluation with MR cholangiography - a case-control study","volume":"215","author":"Fulcher","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2012.11.003_bib47","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib49","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long term follow up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.11.003_bib51","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.003_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib54","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentations, natural history and prognostic variables: an Italian multicenter study","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib55","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cld.2010.03.010","article-title":"Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis","volume":"14","author":"Gotthardt","year":"2010","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.003_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib59","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MCG.0b013e3181646713","article-title":"A\u00a0twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis","volume":"42","author":"Gluck","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2012.11.003_bib61","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00000658-198805000-00016","article-title":"Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis","volume":"207","author":"Cameron","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2012.11.003_bib62","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archsurg.1994.01420340071012","article-title":"Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach","volume":"129","author":"Myburgh","year":"1994","journal-title":"Arch Surg"},{"key":"10.1016\/j.cld.2012.11.003_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","article-title":"Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression","volume":"29","author":"Angulo","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199504000-00011","article-title":"Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis","volume":"20","author":"Jorgensen","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.20029","article-title":"Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis","volume":"39","author":"Zein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib67","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cld.2012.11.003_bib68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2011.10.002","article-title":"Primary sclerosing cholangitis and malignancy","volume":"25","author":"Boberg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib70","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib72","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2012.11.003_bib73","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1572-0241.2001.03696.x","article-title":"Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2007.07.003","article-title":"Cholangiocarcinoma: is transplantation an option? for whom?","volume":"47","author":"Gores","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib75","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib76","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.003_bib77","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.cld.2012.11.003_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365520801977568","article-title":"Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease","volume":"44","author":"Brackmann","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib80","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/DCR.0b013e31822bbcc1","article-title":"Increased risk of colorectal cancer and dysplasia in patients with Chrohn\u2019s colitis and primary sclerosing cholangitis","volume":"54","author":"Lindstrom","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cld.2012.11.003_bib81","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib82","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/bega.2001.0212","article-title":"Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease","volume":"15","author":"Wiesner","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2012.11.003_bib84","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long term follow up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2012.11.003_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.003_bib86","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.003_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T06:52:23Z","timestamp":1595141543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1089326112001419"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.11.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}